CH644453A5 - Methode de detection du cancer. - Google Patents

Methode de detection du cancer. Download PDF

Info

Publication number
CH644453A5
CH644453A5 CH277880A CH277880A CH644453A5 CH 644453 A5 CH644453 A5 CH 644453A5 CH 277880 A CH277880 A CH 277880A CH 277880 A CH277880 A CH 277880A CH 644453 A5 CH644453 A5 CH 644453A5
Authority
CH
Switzerland
Prior art keywords
dna
concentration
protein
cancer
bleomycin
Prior art date
Application number
CH277880A
Other languages
English (en)
French (fr)
Inventor
Stanley T Crooke
Louis Galvan
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of CH644453A5 publication Critical patent/CH644453A5/fr

Links

Classifications

    • G01N33/5755—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G01N33/57585—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
CH277880A 1979-04-10 1980-04-10 Methode de detection du cancer. CH644453A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
CH644453A5 true CH644453A5 (fr) 1984-07-31

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
CH277880A CH644453A5 (fr) 1979-04-10 1980-04-10 Methode de detection du cancer.

Country Status (24)

Country Link
JP (1) JPS55143441A (OSRAM)
KR (1) KR830002502A (OSRAM)
AR (1) AR222700A1 (OSRAM)
AT (1) AT365343B (OSRAM)
AU (1) AU536522B2 (OSRAM)
BE (1) BE882669A (OSRAM)
CH (1) CH644453A5 (OSRAM)
DE (1) DE3013837A1 (OSRAM)
DK (1) DK149980A (OSRAM)
ES (1) ES8103380A1 (OSRAM)
FI (1) FI801078A7 (OSRAM)
FR (1) FR2454099A1 (OSRAM)
GB (1) GB2047712B (OSRAM)
GR (1) GR67692B (OSRAM)
HU (1) HU183122B (OSRAM)
IE (1) IE49981B1 (OSRAM)
IL (1) IL59772A (OSRAM)
IT (1) IT1143135B (OSRAM)
LU (1) LU82345A1 (OSRAM)
NL (1) NL8002094A (OSRAM)
NO (1) NO801018L (OSRAM)
PH (1) PH15637A (OSRAM)
SE (1) SE8002602L (OSRAM)
ZA (1) ZA802141B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR830002502A (ko) 1983-05-30
FR2454099B1 (OSRAM) 1984-01-27
NO801018L (no) 1980-10-13
IE800693L (en) 1980-10-10
LU82345A1 (fr) 1980-12-16
IE49981B1 (en) 1986-01-22
DK149980A (da) 1980-10-11
JPS55143441A (en) 1980-11-08
IT8048370A0 (it) 1980-04-09
ES490396A0 (es) 1981-02-16
GB2047712B (en) 1983-02-23
GR67692B (OSRAM) 1981-09-07
GB2047712A (en) 1980-12-03
AR222700A1 (es) 1981-06-15
NL8002094A (nl) 1980-10-14
AU5719380A (en) 1980-10-16
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
IT1143135B (it) 1986-10-22
FR2454099A1 (fr) 1980-11-07
AT365343B (de) 1982-01-11
IL59772A (en) 1983-05-15
ES8103380A1 (es) 1981-02-16
IL59772A0 (en) 1980-06-30
AU536522B2 (en) 1984-05-10
HU183122B (en) 1984-04-28
SE8002602L (sv) 1980-12-09
PH15637A (en) 1983-03-11
ATA195780A (de) 1981-05-15
FI801078A7 (fi) 1981-01-01
BE882669A (fr) 1980-10-06

Similar Documents

Publication Publication Date Title
Spivak et al. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity diiorder
KR100846354B1 (ko) 혈청 당단백질부터 분리한 폐암 진단용 마커
US8859725B2 (en) Healthy kidney biomarkers
EP2146209B1 (en) Neurodegenerative markers for Alzheimer's disease
Baldini et al. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
FR2461256A1 (fr) Procede et necessaire de diagnostic du cancer par determination des liaisons glucosidiques associees aux tumeurs
KR20090108006A (ko) 혈장-유래된 미세입자로부터 바이오마커를 확인 및 분석하는 방법
CA2088050A1 (en) Cell necrosis detection through assays for spectrum and breakdown products thereof
EP2791681A2 (de) Verfahren zur identifizierung von markersequenzen für gynäkologisches malignom
US4270924A (en) Diagnostic method for detecting cancer
Schwartz et al. Quantitative assay of erythrocyte “free” and zinc-protoporphyrin: Clinical and genetic studies
CH644453A5 (fr) Methode de detection du cancer.
Magni et al. Hydrogel nanoparticle harvesting of plasma or urine for detecting low abundance proteins
JP7589323B2 (ja) 猫の腎機能障害の検査方法
Deby-Dupont et al. Equine neutrophil myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies
Bąchor et al. Identyfication of tryptic podocin peptide in the feline urine sediments using LC-MS/MRM method
KR102608933B1 (ko) 전신 홍반성 루푸스 환자의 루푸스 신염 진단용 바이오마커 조성물 및 이를 이용한 루푸스 신염 진단에 필요한 정보를 제공하는 방법
Kim et al. Comparative analysis of serum proteomes of patients with cardiovascular disease
KR20220126900A (ko) 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법
KR20230042506A (ko) 신경퇴행성 질환의 진단 및 예후에서 마커로서의 p53 번역후 변형
WO2023143650A1 (en) Method for determination of mutated form of mucin-1 protein in a biological sample
KR102451997B1 (ko) 합토글로빈 단백질 또는 합토글로빈 유전자를 이용하는 과민증 진단용 키트 및 과민증을 탐지하는 방법
Miura Application of fluorescence polarization to the determination of urinary lysozyme activity
JP2573189B2 (ja) カリクレインの検出方法
KR20180117918A (ko) Mfap5 측정 제제를 포함하는 대장암 진단용 조성물, 키트, 및 이를 이용한 대장암 진단 방법

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased